{"symbol":"ABBV","fiscalQuarter":"Q4-2016","reportDate":"2017-01-27","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2016","postBrief":{"headline":"AbbVie Misses on EPS, Stock Down 2.07%","keyNumbers":[{"metric":"EPS","actual":"$1.20","expected":"N/A","surprise":"-0.08%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management did not provide specific guidance for the upcoming quarters.","The company acknowledged challenges in the current market environment."],"summary":"Management expressed caution regarding future performance. They highlighted ongoing market challenges but did not provide detailed forecasts."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"AbbVie's earnings report showed a slight miss on EPS, which contributed to a 2.07% decline in stock price. The lack of revenue figures and guidance may have added to investor uncertainty. Overall, the cautious tone from management suggests that the company is facing challenges that could impact future performance.","metaDescription":"AbbVie Inc (ABBV) Q4 2016 earnings: EPS missed. Stock down 2.07%. Full breakdown."}}